Definitive HealthcareDH -3.20%51 PS Ratio is 0.34 as of Jul. 03, 2026, which is 90% below its 10-year median of 3.54. GuruFocus rates DH with a GF Score™ of 51/100 and a GF Value™ of $4.44 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 659 Healthcare Providers & Services companies, Definitive Healthcare ranks better than 87.71% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Definitive Healthcare's share price is $0.7791.
Definitive Healthcare's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $2.28. Hence, Definitive Healthcare's PS Ratio for today is 0.34.
The historical rank and industry rank for Definitive Healthcare's PS Ratio or its related term are showing as below:
DH'
s PS Ratio Range Over the Past 10 Years
Min: 0.29 Med: 3.54 Max: 30.5
Current: 0.34
During the past 7 years, Definitive Healthcare's highest PS Ratio was 30.50. The lowest was 0.29. And the median was 3.54.
DH's PS Ratio is ranked better than 87.71% of 659
companies
in the Healthcare Providers & Services industry
Industry Median: 1.52
vs DH: 0.34
During the past 7 years, Definitive Healthcare's highest 3-Year average Revenue per Share Growth Rate was 18.20% per year. The lowest was 0.90% per year. And the median was 6.10% per year.
Back to Basics: PS Ratio
Definitive Healthcare (NAS:DH) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Definitive Healthcare's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Definitive Healthcare PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Definitive Healthcare's PS Ratio distribution charts can be found below:
* The bar in red indicates where Definitive Healthcare's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Definitive Healthcare's Share Price of today is $0.7791. Definitive Healthcare's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.28.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Definitive Healthcare (DH) has a PS Ratio of 0.34 as of Jul. 03, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Definitive Healthcare and its competitors. This is 90% below median its historical median of 3.54. Over the past decade, Definitive Healthcare's PS Ratio has ranged from 0.29 to 30.50. According to the industry distribution chart, Definitive Healthcare ranks #81 out of 659 companies in the Healthcare Providers & Services industry, placing it in the top 12.3%.
Is Definitive Healthcare's PS Ratio too high?
Definitive Healthcare's current PS Ratio of 0.34 is 90% below median its 10-year median of 3.54. Over the past 10 years, this metric has ranged from a low of 0.29 to a high of 30.50. The Healthcare Providers & Services industry median PS Ratio is 1.52. Definitive Healthcare's value of 0.34 is 77.6% below this industry median. Based on the distribution chart, Definitive Healthcare ranks #81 out of 659 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Definitive Healthcare has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Definitive Healthcare's PS Ratio compare to DRIO and CCLD?
According to the Healthcare Providers & Services industry distribution chart, Definitive Healthcare ranks #81 out of 659 companies for PS Ratio. This places Definitive Healthcare in the top 12% of its industry — outperforming the majority of peers. The industry median PS Ratio is 1.52. Definitive Healthcare's value of 0.34 is 77.6% below this benchmark. Historically, Definitive Healthcare's own PS Ratio has ranged from 0.29 to 30.50 over the past decade. While the company's 10-year median is 3.54 vs. the industry median of 1.52, Definitive Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.52, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Definitive Healthcare's current PS Ratio of 0.34 is 77.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Definitive Healthcare and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Definitive Healthcare's current PS Ratio is 0.34, which is 90% below median its own 10-year median of 3.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Definitive Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Definitive Healthcare (DH) is currently considered Possible Value Trap. The stock's GF Value™ is $4.44, compared to a current price of $0.78 — trading 82.5% below its estimated fair value. The current PS Ratio is 0.34, which is 90% below median its 10-year median of 3.54 and 77.6% below the Healthcare Providers & Services industry median of 1.52. Definitive Healthcare's overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Definitive Healthcare (DH), the current PS Ratio is 0.34 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Definitive Healthcare (DH) Overvalued in 2026?
Based on GuruFocus' analysis, Definitive Healthcare stock appears to be undervalued.
The current stock price of $0.78 is trading 82.5% below its estimated GF Value™ of $4.44.
GuruFocus considers Definitive Healthcare to be Possible Value Trap.
Key valuation signals for DH:
PS Ratio: 0.34 (90% below median its 10-year median of 3.54)
GF Value™: $4.44 vs. price of $0.78 (82.5% below fair value)
Industry Position: 77.6% below the Healthcare Providers & Services median (#81 of 659)
No single metric tells the full story. See the DH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.
51GF Score
Get the complete analysis for DH
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DH has been successfully added to your 
